Ultimele actualizari :
28/04/2024
Infostab
Listele
Listele
Cercetări de compatibilitate
Tabel de compatibilitate Y-site
Bibliografie
Echipe de cercetare
Valistab
Poster
Conexiuni
Sponsori
Autor
Mod de utilizare
Newsletter
Bibliografie 199
Tip :
Ziar
Echipe de cercetare :
Baltimore - University of Maryland, School of Pharmacy
Autor :
Hassan E, Leslie J, Martir-Herrero ML.
Titlu :
Stability of labetalol hydrochloride with selected critical care drugs during simulated Y-site injection.
Référence :
Am J Hosp Pharm ; 51: 2143-2145. 1994
Nivelul dovezii :
Stabilitatea fizică :
Stabilitate chimică :
Alte metode :
Comentarii :
Listele
Dobutamine hydrochloride
2.5 mg/ml
+
Labetalol hydrochloride
1 mg/ml
+
Dopamine hydrochloride
1.6 mg/ml
+
Labetalol hydrochloride
1 mg/ml
+
Labetalol hydrochloride
1 mg/ml
+
Dobutamine hydrochloride
2.5 mg/ml
+
1 mg/ml
+
Dopamine hydrochloride
1.6 mg/ml
+
1 mg/ml
+
Morphine sulfate
0.5 mg/ml
+
1 mg/ml
+
Nitroglycerin
0.2 mg/ml
+
1 mg/ml
+
Ranitidine hydrochloride
0.6 mg/ml
+
Morphine sulfate
0.5 mg/ml
+
Labetalol hydrochloride
1 mg/ml
+
Nitroglycerin
0.2 mg/ml
+
Labetalol hydrochloride
1 mg/ml
+
Ranitidine hydrochloride
0.6 mg/ml
+
Labetalol hydrochloride
1 mg/ml
+
20°C-25°C
Labetalol hydrochloride
1 mg/ml
Dobutamine hydrochloride
2,5 mg/ml
4
20°C-25°C
Labetalol hydrochloride
1 mg/ml
Dopamine hydrochloride
1,6 mg/ml
4
20°C-25°C
Labetalol hydrochloride
1 mg/ml
Morphine sulfate
0,5 mg/ml
4
20°C-25°C
Labetalol hydrochloride
1 mg/ml
Nitroglycerin
0,2 mg/ml
4
20°C-25°C
Labetalol hydrochloride
1 mg/ml
Ranitidine hydrochloride
0,6 mg/ml
4
Mentions Légales
